Cargando…

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulk, S, Berkhof, J, Bulkmans, N W J, Zielinski, G D, Rozendaal, L, van Kemenade, F J, Snijders, P J F, Meijer, C J L M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361088/
https://www.ncbi.nlm.nih.gov/pubmed/16404371
http://dx.doi.org/10.1038/sj.bjc.6602915
_version_ 1782153138390695936
author Bulk, S
Berkhof, J
Bulkmans, N W J
Zielinski, G D
Rozendaal, L
van Kemenade, F J
Snijders, P J F
Meijer, C J L M
author_facet Bulk, S
Berkhof, J
Bulkmans, N W J
Zielinski, G D
Rozendaal, L
van Kemenade, F J
Snijders, P J F
Meijer, C J L M
author_sort Bulk, S
collection PubMed
description We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated with HPV18 (OR(MH) 15.0; 95% CI 8.6–26.1 and 21.8; 95% CI 11.9–39.8, respectively) than normal cytology. Human papillomavirus16 was only associated with adenocarcinoma and ACIS after exclusion of HPV18-positive cases (OR(MH) 6.6; 95% CI 2.8–16.0 and 9.4; 95% CI 2.8–31.2, respectively). For SCC, HPV16 prevalence was elevated (OR(MH) 7.0; 95% CI 3.9–12.4) compared to cases with normal cytology, and HPV18 prevalence was only increased after exclusion of HPV16-positive cases (OR(MH) 4.3; 95% CI 1.6–11.6). These results suggest that HPV18 is mainly a risk factor for the development of adenocarcinoma whereas HPV16 is associated with both SCC and adenocarcinoma.
format Text
id pubmed-2361088
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23610882009-09-10 Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands Bulk, S Berkhof, J Bulkmans, N W J Zielinski, G D Rozendaal, L van Kemenade, F J Snijders, P J F Meijer, C J L M Br J Cancer Epidemiology We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated with HPV18 (OR(MH) 15.0; 95% CI 8.6–26.1 and 21.8; 95% CI 11.9–39.8, respectively) than normal cytology. Human papillomavirus16 was only associated with adenocarcinoma and ACIS after exclusion of HPV18-positive cases (OR(MH) 6.6; 95% CI 2.8–16.0 and 9.4; 95% CI 2.8–31.2, respectively). For SCC, HPV16 prevalence was elevated (OR(MH) 7.0; 95% CI 3.9–12.4) compared to cases with normal cytology, and HPV18 prevalence was only increased after exclusion of HPV16-positive cases (OR(MH) 4.3; 95% CI 1.6–11.6). These results suggest that HPV18 is mainly a risk factor for the development of adenocarcinoma whereas HPV16 is associated with both SCC and adenocarcinoma. Nature Publishing Group 2006-01-16 2005-12-13 /pmc/articles/PMC2361088/ /pubmed/16404371 http://dx.doi.org/10.1038/sj.bjc.6602915 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Bulk, S
Berkhof, J
Bulkmans, N W J
Zielinski, G D
Rozendaal, L
van Kemenade, F J
Snijders, P J F
Meijer, C J L M
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title_full Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title_fullStr Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title_full_unstemmed Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title_short Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
title_sort preferential risk of hpv16 for squamous cell carcinoma and of hpv18 for adenocarcinoma of the cervix compared to women with normal cytology in the netherlands
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361088/
https://www.ncbi.nlm.nih.gov/pubmed/16404371
http://dx.doi.org/10.1038/sj.bjc.6602915
work_keys_str_mv AT bulks preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT berkhofj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT bulkmansnwj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT zielinskigd preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT rozendaall preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT vankemenadefj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT snijderspjf preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands
AT meijercjlm preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands